NCT07477886 Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer
| NCT ID | NCT07477886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 134 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 134 participants in total. It began in 2026-02-10 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study uses ambient sensing rooms to collect data from hospitalized cancer patients in order to improve safety and recovery. Being hospitalized increases the risk for delirium (acute confusion), falls, troubles sleeping, and mood changes. Ambient sensing rooms are special rooms that use technology including a video camera to watch the room, an audio recorder to listen to sounds, and a temperature sensor (thermography) to check how warm or cool the room and people are. These tools may help nurses and doctors notice problems early, give better care, and keep patients safe and comfortable.
Eligibility Criteria
Inclusion Criteria: * Patients: * Age \>= 18 * Not receiving comfort/end-of-life care * Not incarcerated * Admitted to one of the six rooms equipped with ambient technology * History of cancer or has a cancer diagnosis * Clinicians: * Age \>= 18 * Participating in direct patient care activities on Eisenberg units 4-3 as an employee of Mayo Clinic Exclusion Criteria: * Patients: * Age \< 18 years * Receiving comfort or end-of-life care * Incarceration (prisoner status) * Primary language is not English * Clinicians: * Age \< 18 years
Contact & Investigator
Allyson K Palmer, MD, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07477886 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07477886 currently recruiting?
Yes, NCT07477886 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT07477886 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07477886 clinical trial?
NCT07477886 is sponsored by Mayo Clinic. The principal investigator is Allyson K Palmer, MD, PhD at Mayo Clinic. The trial plans to enroll 134 participants.